MPE endorses the International COVID-19 Blood Cancer Coalition’s (ICBCC) patient impact statement
A multi-stakeholder coalition consisting of more than 60 representatives from the global patient advocacy and clinical community has formed the International COVID-19 Blood Cancer Coalition (ICBCC) to address the specific impact of the pandemic on immunocompromised blood cancer patients and to recommend solutions and actions to mitigate those risks. The special vulnerability of those with blood cancers and others needs to be addressed in a proactive way. While we need to be prepared for surprises…